Same drug, thousands of prices: Crossing Medicare’s Catastrophic Coverage finish line
Ben LinkMedicare, PBM, Part D, Copaxone, Inflation Reduction Act, Catastrophic Coverage, IRA, NADAC, Mark Cuban, MFP, Januvia, Novolog, Farxiga, Enbrel, Jardiance, Stelara, Xarelto, Eliquis, Entresto, Imbruvica, WAC, Express Scripts, CVS, Optum, Kaiser, 340B
Wreck-fidera: How Medicare Part D has hidden the benefits of generic competition for a blockbuster Multiple Sclerosis treatment
Ben LinkMedicare, Copaxone, Teva, Rebates, Tecfidera, Biogen, Multiple Sclerosis, WAC, Mylan, NADAC, specialty drugs, Kaiser, CVS, UnitedHealthcare, Cigna, Anthem, Humana, Centene, DIR fees, AWP, Plan Finder
The Flawed Design of Medicare Part D: A Copaxone Case Study
Ben LinkCopaxone, glatiramer, Medicare, Part D, PBM, specialty drugs, Gleevec, ACA, Drug prices, Teva, Mylan, Sandoz, Deductible, Rebates, DIR fees
